Innovent Biologics (6IB) Q2 2026 Earnings Report
DE:6IB Q2 2026 EPS Results
- Actual EPS
- EUR 0.09
- Consensus EPS
- EUR 0.06
- Beat/Miss
- Beat by +EUR 0.03
- One Year Ago EPS
- EUR 0.07
DE:6IB Q2 2026 Revenue Results
- Actual Revenue
- EUR 1.12B
- Expected Revenue
- EUR 1.20B
- Beat/Miss
- Missed by -EUR 74.57M
- YoY Revenue Growth
- +53.63%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/25/2026
- Time
- Before Open
- Conference Call
- Tuesday, August 25, 2026
DE:6IB Upcoming Earnings
Innovent Biologics's next earnings date is estimated for March 31, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:6IB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 31, 2027 | 2026 (Q4) | 0.15- | 0 | ― | ― |
| Aug 25, 2026 | 2026 (Q2) | 0.060.09 | 0.07 | 37.25% (+0.03) | |
| Mar 26, 2026 | 2025 (Q4) | 0.02-0.00 | 0.02 | -105.56% (-0.03) | |
| Aug 27, 2025 | 2025 (Q2) | 0.020.07 | -0.03 | 312.50% (+0.10) | |
| Mar 26, 2025 | 2024 (Q4) | -0.030.02 | -0.08 | 131.69% (+0.10) | |
| Aug 28, 2024 | 2024 (Q2) | -0.03-0.03 | -0.01 | -166.67% (-0.02) | |
| Mar 20, 2024 | 2023 (Q4) | -0.09-0.08 | -0.11 | 32.38% (+0.04) | |
| Aug 23, 2023 | 2023 (Q2) | -0.09-0.01 | -0.09 | 86.15% (+0.08) | |
| Mar 31, 2023 | 2022 (Q4) | -0.09-0.11 | -0.18 | 37.78% (+0.07) | |
| Aug 25, 2022 | 2022 (Q2) | -0.91-0.09 | -0.11 | 19.75% (+0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed